Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant

Summary

The aims of this study are to prospectively evaluate the efficacy of two intravenous infusions of pamidronate 90 mg, associated with calcium and calcidiol, in the early post-transplant period, on bone loss in liver transplant recipients, and to asses the safety of this treatment.

Timeline

Start

2000-12

Primary completion

2003-12

Completion

2003-12

Drugs

Indications